• Torin2: Turning mTOR Potency Into Translational Insight

  2026-08-21

  Torin2 is more than a potent mTOR inhibitor: it is a strategic tool for separating pathway suppression, growth arrest, apoptosis, migration, and exposure in translational cancer research.

• SEMA3E and β-Catenin in Beige Fat Thermogenesis

  2026-08-20

  This mouse study identifies SEMA3E as a positive regulator of beige adipocyte differentiation and thermogenesis, linking the semaphorin family to mitochondrial oxidative phosphorylation and β-catenin pathway control. Its combination of genetic perturbation, adipose transplantation, transcriptomics, and respiration measurements provides a mechanistic framework for studying thermogenic fat biology.

• 7-AAD Cell Viability Assay Kit for CAR-T Studies

  2026-08-20

  Use the 7-AAD Cell Viability Assay Kit to distinguish membrane-compromised cells from viable populations in CAR-T development, with compatibility for flow cytometry, microscopy, and multiplex apoptosis panels. Its far-red emission profile helps preserve FITC-, PE-, and APC-based measurements while revealing late apoptosis and necrosis.

• AZD6482: Selective PI3Kβ Inhibitor Guide

  2026-08-19

  AZD6482 is an ATP-competitive PI3Kβ inhibitor with strong isoform selectivity and reported activity in platelet and adipocyte assays. Its evidence supports controlled research on PI3Kβ signaling, but it does not establish clinical efficacy or activity in DM1 RNA-foci models.

• Cy3 NHS ester (non-sulfonated): Practical Guide

  2026-08-19

  Cy3 NHS ester (non-sulfonated) provides a reactive fluorescent handle for labeling amino-containing proteins, peptides, oligonucleotides, and DNA. Because it is water-insoluble and requires DMSO or DMF as a co-solvent, it is best suited to workflows that tolerate controlled organic solvent exposure rather than strictly aqueous labeling.

• TBK1, Microglia Pyroptosis, and Diabetic Neuropathy

  2026-08-18

  Liao et al. identify TANK-binding kinase 1 (TBK1) as a mechanistic link between spinal microglial pyroptosis and painful diabetic neuropathy. Using genetic, pharmacological, behavioral, vascular, and tissue-level analyses in type 1 and type 2 diabetes models, the study shows that TBK1 inhibition reduces hyperalgesia and peripheral nerve injury, while defining a TBK1–NF-κB–NLRP3 pathway for further investigation.

• SERCA-ER Stress and HSC Mobilization

  2026-08-18

  Li, Xu, and Huang identify SERCA inhibition as a route to enhance hematopoietic stem cell mobilization through mild endoplasmic reticulum stress. Their data connect SERCA activity with the CaMKII–STAT3–CXCR4 axis and provide a mechanistic framework for improving stem-cell collection beyond conventional cytokine mobilization.

• Anti-ROR1 Antibody Workflow for ROR1 Studies

  2026-08-17

  Anti-ROR1 Antibody (Zilovertamab) enables flexible ROR1 binding, signaling, and cell-based studies with one unconjugated IgG1 reagent. This guide connects Wnt5a-induced ROR1 signaling inhibition in cancer models with carefully controlled, exploratory workflows for DON-related liver injury research.

• Rotenone Workflows for Mitochondrial Stress Models

  2026-08-17

  Build reproducible mitochondrial stress, apoptosis, autophagy, and Parkinson’s disease experiments with Rotenone, a defined mitochondrial Complex I inhibitor. This guide connects practical cell-based workflows with the circ-Pank1/miR-7a-5p/α-syn pathway and provides dose, timing, handling, and troubleshooting strategies.

• Naftifine HCl: Assay Workflows & Optimization

  2026-08-16

  Build more reproducible antifungal experiments with Naftifine HCl, from solvent-optimized stock preparation to sterol-pathway validation and cellular counter-screens. The workflow also shows how the WNT5a/GSK3/β-catenin study can inform assay architecture without misclassifying an antifungal probe as a muscle-signaling modulator.

• Dextran sulfate sodium salt in DSS colitis models

  2026-08-15

  Build a reproducible intestinal inflammation model with Dextran sulfate sodium salt and connect barrier injury to epithelial repair biology. This workflow shows how to tune exposure, capture colonic epithelial apoptosis induction, and translate DSS phenotypes into GPR35–KLF5 mechanism-focused assays.

• Silybin A: Reliable Cell-Assay Workflows

  2026-08-14

  This scenario-based guide shows how Silybin A, SKU N1711, can improve control of solubility, vehicle effects, dose-response design, and assay interpretation in viability and cytotoxicity studies. It connects product specifications with practical laboratory decisions and literature on silybin chemistry.

• FKBP9, ER Stress, and Glioblastoma Malignancy

  2026-08-14

  The 2020 study by Xu et al. identifies FKBP9 as an ER-resident driver of glioblastoma aggressiveness and resistance to ER stress inducers. Its combination of clinical analysis, pathway dissection, cellular assays, and in vivo models links FKBP9 to ASK1–p38MAPK signaling and the IRE1α–XBP1 unfolded protein response.

• DOPE: From Membrane Fusion to Translational Strategy

  2026-08-13

  A mechanistic and translational analysis of 1,2-Dioleoyl-sn-glycero-3-PE (DOPE), connecting its endosomal membrane-fusion role in nucleic acid delivery with new evidence that phosphatidylethanolamines can influence ferroptotic conidial death in Magnaporthe oryzae.

• MTT Assays: From Metabolic Signal to Translation

  2026-08-13

  MTT is more than a routine viability reagent: it is a mechanistically informative readout of cellular reducing capacity. This thought-leadership guide shows how to deploy 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide strategically when evaluating complex therapeutic concepts such as nitric-oxide-driven nanomotors for glioblastoma.

3614 records 2/241 page Previous Next 12345 下5页 Last page